Search

Your search keyword '"M.-L. Yu"' showing total 39 results

Search Constraints

Start Over You searched for: Author "M.-L. Yu" Remove constraint Author: "M.-L. Yu" Topic business Remove constraint Topic: business
39 results on '"M.-L. Yu"'

Search Results

1. Independent and additive interaction between polymorphisms of tumor necrosis factor α −308 and lymphotoxin α +252 on risk of hepatocellular carcinoma related to hepatitis B

2. Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma

3. Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

4. Investigation of Selected Baseline Removal Techniques as Candidates for Automated Implementation

5. Changes in markers of liver function in hepatitis C virus genotype 1b Asian patients with compensated cirrhosis treated with ombitasvir/paritaprevir/ritonavir plus dasabuvir with ribavirin in the ONYX-II study

6. Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patients

7. Serum Insulin-Like Growth Factor-II and α-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma

8. Segmentation and recognition of Chinese bank check amounts

10. Blood Serum Levels of PCBs and PCDFs in Yucheng Women 14 Years After Exposure to a Toxic Rice Oil

11. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma

12. Significantly lower rates of cirrhosis and worse long-term survival in cryptogenic hepatocellular carcinoma compared to viral etiologies: results of a multi-center international cohort

13. Impact of hepatoprotective medications on the safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in hepatitis C virus genotype lb-infected Asian patients with and without cirrhosis in the ONYX-I and -II studies

14. The optimal cutoff value of serum alpha-fetoprotein in the diagnosis of hepatocellular carcinoma

15. TG-2349, a Potent Protease Inhibitor, Plus Pegifn/RBV Provides Excellent Virological Responses for Harder-To-Treat Subpopulations of HCV-1B Non-Cirrhotic Patients

16. Tip artifacts in atomic force microscope imaging of ion bombarded nanostructures on germanium surfaces

18. Accuracy and precision of manual baseline determination

19. 1171 MICRORNA EXPRESSION PROFILING IN PERIPHERAL BLOOD MONONUCLEAR CELLS IDENTIFIES TWO MIRNAS ASSOCIATED WITH TREATMENT RESPONSE TO PEGINTERFERON-RIBAVIRIN IN CHRONIC HEPATITIS C VIRUS PATIENTS

20. An electron beam microcolumn for multi-beam applications

21. CS4.1 Personalized medicine for HCV treatment

24. 1053 ASSOCIATION BETWEEN DIABETES MELLITUS, HEPATIC STEATOSIS AND FIBROSIS IN CHRONIC HEPATITIS C PATIENTS IN TAIWAN

25. Electron-beam microcolumn technology and applications

27. 617 EFFICACY AND SAFETY OF PEGYLATED INTERFERON- ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS

28. 621 A simple non-invasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy

29. Preventive effects of antiviral therapy on progression of chronic hepatitis C virus infection to liver cirrhosis and hepatocellular carcinoma in Taiwan

31. Thin-film gated photocathodes for electron-beam lithography

33. Experimental evaluation of a 20×20 mm footprint microcolumn

34. Miniature Schottky electron source

35. An electron-beam microcolumn with improved resolution, beam current, and stability

36. Evaluation of Zr/O/W Schottky emitters for microcolumn applications

37. Oxygen processed field emission tips for microcolumn applications

38. Self-synchronous parametric amplification using Josephson junctions

39. Fuel Sulfur Reduction for Control of Diesel Particulate Emissions

Catalog

Books, media, physical & digital resources